Skip to content

Insider · CIK 0001704336

Michael Cloonan

ceopresidentofficerdirector

Files at BLUE (bluebird bio, Inc.), SION (Sionna Therapeutics, Inc.). First filing Aug 21, 2025, latest Sep 30, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $1.9M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SION: Sionna Therapeutics, Inc.

SIONOct 9, 2026 · close 4.90

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
11Weak
SIONsell10b5-1
Sionna Therapeutics, Inc.
$728k
25,000 shares
-4%+278% from low0% from high
18Weak
SIONsell 210b5-1
Sionna Therapeutics, Inc.
$624k
25,000 shares
-4%+229% from low0% from high
9Weak
SIONsell10b5-1
Sionna Therapeutics, Inc.
$569k
25,000 shares
-4%+197% from low-9% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 17, 2026SION
Sionna Therapeutics, Inc.
AGrant or award
Common Stock
+109,025$0.00$0656,36824 d ago
Sep 17, 2026SION
Sionna Therapeutics, Inc.
AGrant or award
Common Stock
+109,025$0.00$0765,39324 d ago
Sep 17, 2026SION
Sionna Therapeutics, Inc.
AGrant or award
Non-Qualified Stock Option (right to buy)derivative
+436,100$0.00$0436,10024 d ago
Sep 17, 2026SION
Sionna Therapeutics, Inc.
DDisposition to issuer
Non-Qualified Stock Option (right to buy)derivative
-436,100$0.00$0024 d ago
Sep 26, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+17,207$6.11$105k564,550Sep 30, 2025
Sep 26, 2025SION
Sionna Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-17,207$28.85$496k547,343Sep 30, 2025
Sep 29, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+7,793$6.11$48k555,136Sep 30, 2025
Sep 29, 2025SION
Sionna Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-7,793$29.70$231k547,343Sep 30, 2025
Sep 26, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-17,207$0.00$0185,935Sep 30, 2025
Sep 29, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-7,793$0.00$0178,142Sep 30, 2025
Aug 26, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+17,574$6.11$107k564,917Aug 28, 2025
Aug 26, 2025SION
Sionna Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-17,574$24.96$439k547,343Aug 28, 2025
Aug 27, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+7,426$6.11$45k554,769Aug 28, 2025
Aug 27, 2025SION
Sionna Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-7,426$25.01$186k547,343Aug 28, 2025
Aug 26, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-17,574$0.00$0210,568Aug 28, 2025
Aug 27, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-7,426$0.00$0203,142Aug 28, 2025
Aug 20, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+25,000$6.11$153k572,343Aug 21, 2025
Aug 20, 2025SION
Sionna Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-25,000$22.75$569k547,343Aug 21, 2025
Aug 20, 2025SION
Sionna Therapeutics, Inc.
MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-25,000$0.00$0228,142Aug 21, 2025
Jun 2, 2025BLUE
bluebird bio, Inc.
DDisposition to issuer
Common Stock
-1,867--0Jun 3, 2025
Feb 6, 2025SION
Sionna Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+450,252$0.00$0450,252Feb 10, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael Cloonan: insider trades and track record | InsiderTell